REGN – Regeneron Pharmaceuticals
Investors holding1
Combined shares105,934
Combined reported value$80.3M
REGN chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Ray Dalio narrow view | 0.35 | Added 106.4% | 105,934 | $80.3M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Ray Dalio narrow view | Added 106.4% | 105,934 | 0.18 |
| Q2 2026 | Ray Dalio narrow view | Added 125.9% | 51,333 | 0.07 |
| Q1 2026 | Ray Dalio narrow view | Reduced 68.8% | 22,724 | 0.17 |
| Q1 2026 | Cathie Wood | Closed | 0 | 0.00 |
| Q4 2025 | Ray Dalio narrow view | Reduced 69.1% | 72,745 | 0.46 |
| Q4 2025 | Cathie Wood | Reduced 99.1% | 110 | 0.06 |
Added: opened or increased
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q1 2026 | Ray Dalio narrow view | Reduced 68.8% | 22,724 | 0.17 |
| Q1 2026 | Cathie Wood | Closed | 0 | 0.00 |
| Q4 2025 | Ray Dalio narrow view | Reduced 69.1% | 72,745 | 0.46 |
| Q4 2025 | Cathie Wood | Reduced 99.1% | 110 | 0.06 |
History
3 peakQ3 2026: 1 tracked investors
20132026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Ray Dalio | 105.9K | 51.3K | 22.7K | 72.7K | 235.4K | 89.0K | 21.0K | 289 |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).